Assay
Age
|
In situ reporter (knock in)
11.5 DPC
|
Nat2 N-acetyltransferase 2 (arylamine N-acetyltransferase) | |
Results | Reference |
1 | J:84738 Cornish VA, Pinter K, Boukouvala S, Johnson N, Labrousse C, Payton M, Priddle H, Smith AJ, Sim E, Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene. Pharmacogenomics J. 2003;3(3):169-77 |
1* | J:98097 Wakefield L, Cornish V, Broackes-Carter F, Sim E, Arylamine N-acetyltransferase 2 Expression in the Developing Heart. J Histochem Cytochem. 2005 May;53(5):583-92 |
1* | J:127891 Wakefield L, Cornish V, Long H, Kawamura A, Zhang X, Hein DW, Sim E, Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system. Biomarkers. 2007 Sep 25;:1-13 |
1* | J:121985 Wakefield L, Long H, Lack N, Sim E, Ocular defects associated with a null mutation in the mouse arylamine N-acetyltransferase 2 gene. Mamm Genome. 2007 Apr;18(4):270-6 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/02/2024 MGI 6.24 |
![]() |
|